From: Kinome expression profiling and prognosis of basal breast cancers
 | Univariate Analysis |  | Multivariate Analysis* |  |  | |||
---|---|---|---|---|---|---|---|---|
 | N | HR [95%CI] | p -value | N | HR [95%CI] | p -value | HR [95%CI] | p -value |
Age ≤ 50 ( vs > 50y) | 253 | 0.96 [0.65-1.41] | 0.84 |  |  |  |  |  |
pT > 20 mm ( vs ≤ 20 mm) | 275 | 1.40 [0.93-2.11] | 0.11 |  |  |  |  |  |
pN pos ( vs neg) | 301 | 1.53 [1.04-2.25] | 0.032 | 301 | 1.58 [1.07-2.33] | 0.021 | 1.46 [0.99-2.16] | 0.06 |
Grd 2-3 ( vs 1) | 302 | 3.00 [0.74-12.1] | 0.12 | Â | Â | Â | Â | Â |
ER pos ( vs neg) | 315 | 0.68 [0.45-1.03] | 0.07 | Â | Â | Â | Â | Â |
Chemotherapy | 236 | 1.28 [0.77-2.14] | 0.34 | Â | Â | Â | Â | Â |
Hormone therapy | 250 | 1.01 [0.41-2.48] | 0.98 | Â | Â | Â | Â | Â |
MBC-based classifier | 380 | 0.59 [0.43-0.82] | 1.72 E-04 | 301 | Â | Â | 0.59 [0.40-0.87] | 7.5 E-03 |
Immune metagene High ( vs Low) | 380 | 0.45 [0.29-0.69] | 2.4 E04 | 301 | 2.15 [1.32-3.50] | 0.0022 | 0.54 [0.33-0.89] | 0.015 |